

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to muscle activity (GO:0014850) | 4.98723209 |
| 2 | cellular response to zinc ion (GO:0071294) | 4.57152181 |
| 3 | barbed-end actin filament capping (GO:0051016) | 4.29722679 |
| 4 | regulation of oxidative phosphorylation (GO:0002082) | 4.27781912 |
| 5 | regulation of oxidative stress-induced neuron death (GO:1903203) | 4.18523528 |
| 6 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.03530427 |
| 7 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 4.03300464 |
| 8 | regulation of autophagic vacuole assembly (GO:2000785) | 3.86054591 |
| 9 | coenzyme catabolic process (GO:0009109) | 3.81782694 |
| 10 | negative regulation of response to reactive oxygen species (GO:1901032) | 3.67071958 |
| 11 | cellular response to cadmium ion (GO:0071276) | 3.60723725 |
| 12 | activation of protein kinase B activity (GO:0032148) | 3.56332026 |
| 13 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 3.56330370 |
| 14 | positive regulation of catecholamine secretion (GO:0033605) | 3.52351127 |
| 15 | response to peptidoglycan (GO:0032494) | 3.46081635 |
| 16 | regulation of vacuole organization (GO:0044088) | 3.32249363 |
| 17 | muscle cell cellular homeostasis (GO:0046716) | 3.28729699 |
| 18 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.20299004 |
| 19 | AMP metabolic process (GO:0046033) | 3.19911407 |
| 20 | ADP metabolic process (GO:0046031) | 3.15182506 |
| 21 | protein localization to endosome (GO:0036010) | 3.13995560 |
| 22 | regulation of mononuclear cell migration (GO:0071675) | 3.03908929 |
| 23 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.03642774 |
| 24 | cofactor catabolic process (GO:0051187) | 3.01248033 |
| 25 | virion attachment to host cell (GO:0019062) | 2.96178704 |
| 26 | adhesion of symbiont to host cell (GO:0044650) | 2.96178704 |
| 27 | hyaluronan catabolic process (GO:0030214) | 2.95552424 |
| 28 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.93605042 |
| 29 | adhesion of symbiont to host (GO:0044406) | 2.92095183 |
| 30 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.89933031 |
| 31 | regulation of phosphoprotein phosphatase activity (GO:0043666) | 2.81048414 |
| 32 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176) | 2.80612880 |
| 33 | cellular response to arsenic-containing substance (GO:0071243) | 2.80356091 |
| 34 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.79212080 |
| 35 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.78674184 |
| 36 | oligosaccharide catabolic process (GO:0009313) | 2.74838293 |
| 37 | pinocytosis (GO:0006907) | 2.71502288 |
| 38 | membrane raft organization (GO:0031579) | 2.71092308 |
| 39 | eosinophil chemotaxis (GO:0048245) | 2.67797938 |
| 40 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.67214235 |
| 41 | xenobiotic catabolic process (GO:0042178) | 2.63130323 |
| 42 | low-density lipoprotein particle clearance (GO:0034383) | 2.60395627 |
| 43 | androgen biosynthetic process (GO:0006702) | 2.59612355 |
| 44 | cell adhesion mediated by integrin (GO:0033627) | 2.58936304 |
| 45 | negative regulation of platelet activation (GO:0010544) | 2.58685558 |
| 46 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.57165991 |
| 47 | regulation of phospholipase A2 activity (GO:0032429) | 2.56902750 |
| 48 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.55464579 |
| 49 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.55189258 |
| 50 | negative regulation of defense response to virus (GO:0050687) | 2.49388674 |
| 51 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.48825472 |
| 52 | positive regulation of macrophage differentiation (GO:0045651) | 2.48736587 |
| 53 | regulation of chemokine biosynthetic process (GO:0045073) | 2.48270835 |
| 54 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.47166579 |
| 55 | glycogen metabolic process (GO:0005977) | 2.46259574 |
| 56 | response to thyroid hormone (GO:0097066) | 2.44995257 |
| 57 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 2.44329562 |
| 58 | glucan metabolic process (GO:0044042) | 2.40653903 |
| 59 | cellular glucan metabolic process (GO:0006073) | 2.40653903 |
| 60 | cellular zinc ion homeostasis (GO:0006882) | 2.39858617 |
| 61 | regulation of early endosome to late endosome transport (GO:2000641) | 2.38283830 |
| 62 | TOR signaling (GO:0031929) | 2.35140110 |
| 63 | potassium ion export (GO:0071435) | 2.33648527 |
| 64 | mannose metabolic process (GO:0006013) | 2.33420791 |
| 65 | regulation of protein sumoylation (GO:0033233) | 2.31965927 |
| 66 | response to acidic pH (GO:0010447) | 2.31289743 |
| 67 | eosinophil migration (GO:0072677) | 2.31269751 |
| 68 | cortical actin cytoskeleton organization (GO:0030866) | 2.30825039 |
| 69 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.30324525 |
| 70 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.29569861 |
| 71 | glycosphingolipid catabolic process (GO:0046479) | 2.28512171 |
| 72 | cellular response to toxic substance (GO:0097237) | 2.27549113 |
| 73 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.26463084 |
| 74 | positive regulation of extracellular matrix organization (GO:1903055) | 2.26122149 |
| 75 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.25982019 |
| 76 | pyrimidine nucleoside salvage (GO:0043097) | 2.25214782 |
| 77 | pyrimidine-containing compound salvage (GO:0008655) | 2.25214782 |
| 78 | muscle filament sliding (GO:0030049) | 2.24626195 |
| 79 | actin-myosin filament sliding (GO:0033275) | 2.24626195 |
| 80 | response to activity (GO:0014823) | 2.24250718 |
| 81 | regulation of protein kinase C signaling (GO:0090036) | 2.24076262 |
| 82 | positive regulation of interleukin-6 production (GO:0032755) | 2.23194716 |
| 83 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.22253356 |
| 84 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.21592004 |
| 85 | cell volume homeostasis (GO:0006884) | 2.20901636 |
| 86 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.20861702 |
| 87 | negative regulation of interleukin-12 production (GO:0032695) | 2.20505047 |
| 88 | cellular response to interferon-alpha (GO:0035457) | 2.19454446 |
| 89 | neutrophil activation involved in immune response (GO:0002283) | 2.19426264 |
| 90 | relaxation of smooth muscle (GO:0044557) | 2.17982000 |
| 91 | actin-mediated cell contraction (GO:0070252) | 2.17811152 |
| 92 | immunoglobulin mediated immune response (GO:0016064) | 2.17588005 |
| 93 | positive regulation of glycolytic process (GO:0045821) | 2.17290652 |
| 94 | negative regulation of oxidative stress-induced cell death (GO:1903202) | 2.16576043 |
| 95 | regulation of podosome assembly (GO:0071801) | 2.16511837 |
| 96 | myofibril assembly (GO:0030239) | 2.15735545 |
| 97 | regulation of myoblast differentiation (GO:0045661) | 2.15565354 |
| 98 | amino sugar catabolic process (GO:0046348) | 2.15456568 |
| 99 | regulation of macrophage chemotaxis (GO:0010758) | 2.15033184 |
| 100 | fructose metabolic process (GO:0006000) | 2.13185572 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.19339083 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.70681704 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.70024849 |
| 4 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.82613418 |
| 5 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.61385614 |
| 6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.56980755 |
| 7 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.44310829 |
| 8 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.40815458 |
| 9 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.37951317 |
| 10 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.31614554 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.28795500 |
| 12 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.23656375 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.20856832 |
| 14 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.14578846 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.14547806 |
| 16 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.12291735 |
| 17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.08364888 |
| 18 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.93912661 |
| 19 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.93104838 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.87527783 |
| 21 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.81127500 |
| 22 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.79697697 |
| 23 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.77513406 |
| 24 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.69695253 |
| 25 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.68530175 |
| 26 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.68351699 |
| 27 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.62028990 |
| 28 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.61092772 |
| 29 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.59057579 |
| 30 | CJUN_26792858_Chip-Seq_BT549_Human | 1.58081598 |
| 31 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.57271436 |
| 32 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.56551045 |
| 33 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.47729931 |
| 34 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.45264242 |
| 35 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.45129949 |
| 36 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.45129949 |
| 37 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.44104881 |
| 38 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.43253417 |
| 39 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.42966356 |
| 40 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.42873641 |
| 41 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.42759888 |
| 42 | SPI1_23127762_ChIP-Seq_K562_Human | 1.42583873 |
| 43 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.37286392 |
| 44 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.36035775 |
| 45 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.35811960 |
| 46 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.34405417 |
| 47 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.32260113 |
| 48 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.32046632 |
| 49 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.29909711 |
| 50 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.27944008 |
| 51 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.27506470 |
| 52 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26923569 |
| 53 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.25713832 |
| 54 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.22440752 |
| 55 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.22125705 |
| 56 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.22125705 |
| 57 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.20313545 |
| 58 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19342726 |
| 59 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15231422 |
| 60 | ATF3_27146783_Chip-Seq_COLON_Human | 1.15205377 |
| 61 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.14353022 |
| 62 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.13420145 |
| 63 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12735240 |
| 64 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.10199289 |
| 65 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.09618661 |
| 66 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.09583884 |
| 67 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.09093874 |
| 68 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.08515934 |
| 69 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.07694431 |
| 70 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.07214845 |
| 71 | GATA1_22025678_ChIP-Seq_K562_Human | 1.06860410 |
| 72 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.05507567 |
| 73 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.03061285 |
| 74 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01375473 |
| 75 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.99014376 |
| 76 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.98462370 |
| 77 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.98456338 |
| 78 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.97490051 |
| 79 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96487944 |
| 80 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.96336681 |
| 81 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.96232038 |
| 82 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94606723 |
| 83 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.93734884 |
| 84 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.93733552 |
| 85 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.93528969 |
| 86 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.93528969 |
| 87 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.92990855 |
| 88 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.92036944 |
| 89 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.90619424 |
| 90 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.90608116 |
| 91 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.90120955 |
| 92 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.90051690 |
| 93 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.89588743 |
| 94 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89034947 |
| 95 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87998552 |
| 96 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.87750774 |
| 97 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.87706772 |
| 98 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87634957 |
| 99 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.87133720 |
| 100 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85182726 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 4.44279315 |
| 2 | MP0009840_abnormal_foam_cell | 4.43284349 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 4.15650357 |
| 4 | MP0008004_abnormal_stomach_pH | 2.75707110 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 2.67929690 |
| 6 | MP0000749_muscle_degeneration | 2.64971759 |
| 7 | MP0004510_myositis | 2.60197612 |
| 8 | MP0002837_dystrophic_cardiac_calcinosis | 2.52127787 |
| 9 | MP0009697_abnormal_copulation | 2.27536902 |
| 10 | MP0004084_abnormal_cardiac_muscle | 2.24726274 |
| 11 | MP0000343_altered_response_to | 2.19399156 |
| 12 | MP0005451_abnormal_body_composition | 2.19259070 |
| 13 | MP0010368_abnormal_lymphatic_system | 2.16938133 |
| 14 | MP0008438_abnormal_cutaneous_collagen | 2.12670995 |
| 15 | MP0004272_abnormal_basement_membrane | 2.06409296 |
| 16 | MP0003950_abnormal_plasma_membrane | 2.05642617 |
| 17 | MP0003172_abnormal_lysosome_physiology | 2.00702255 |
| 18 | MP0003075_altered_response_to | 1.99762707 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 1.96153620 |
| 20 | MP0006082_CNS_inflammation | 1.93677200 |
| 21 | MP0005360_urolithiasis | 1.89383289 |
| 22 | MP0004036_abnormal_muscle_relaxation | 1.88968791 |
| 23 | MP0010234_abnormal_vibrissa_follicle | 1.87642551 |
| 24 | MP0002138_abnormal_hepatobiliary_system | 1.77057743 |
| 25 | MP0003828_pulmonary_edema | 1.75072798 |
| 26 | MP0009785_altered_susceptibility_to | 1.70956516 |
| 27 | MP0003191_abnormal_cellular_cholesterol | 1.66579419 |
| 28 | MP0005166_decreased_susceptibility_to | 1.60778404 |
| 29 | MP0003868_abnormal_feces_composition | 1.56923056 |
| 30 | MP0002998_abnormal_bone_remodeling | 1.56763420 |
| 31 | MP0001835_abnormal_antigen_presentation | 1.46954563 |
| 32 | MP0003091_abnormal_cell_migration | 1.45051141 |
| 33 | MP0005330_cardiomyopathy | 1.42694388 |
| 34 | MP0002877_abnormal_melanocyte_morpholog | 1.38510684 |
| 35 | MP0005410_abnormal_fertilization | 1.36873269 |
| 36 | MP0009780_abnormal_chondrocyte_physiolo | 1.36532264 |
| 37 | MP0004233_abnormal_muscle_weight | 1.36418954 |
| 38 | MP0002132_abnormal_respiratory_system | 1.35443042 |
| 39 | MP0001849_ear_inflammation | 1.34866134 |
| 40 | MP0005165_increased_susceptibility_to | 1.33364551 |
| 41 | MP0003303_peritoneal_inflammation | 1.32941434 |
| 42 | MP0003300_gastrointestinal_ulcer | 1.32029073 |
| 43 | MP0002332_abnormal_exercise_endurance | 1.31128752 |
| 44 | MP0003436_decreased_susceptibility_to | 1.28531331 |
| 45 | MP0002419_abnormal_innate_immunity | 1.27499106 |
| 46 | MP0010386_abnormal_urinary_bladder | 1.23732105 |
| 47 | MP0005164_abnormal_response_to | 1.21067700 |
| 48 | MP0002269_muscular_atrophy | 1.19634469 |
| 49 | MP0000604_amyloidosis | 1.16386561 |
| 50 | MP0000759_abnormal_skeletal_muscle | 1.13848080 |
| 51 | MP0005464_abnormal_platelet_physiology | 1.13357461 |
| 52 | MP0003195_calcinosis | 1.10626507 |
| 53 | MP0003453_abnormal_keratinocyte_physiol | 1.10545614 |
| 54 | MP0001661_extended_life_span | 1.09578429 |
| 55 | MP0000747_muscle_weakness | 1.05575466 |
| 56 | MP0003724_increased_susceptibility_to | 1.04646651 |
| 57 | MP0008469_abnormal_protein_level | 1.03882056 |
| 58 | MP0005025_abnormal_response_to | 1.03166726 |
| 59 | MP0001533_abnormal_skeleton_physiology | 1.00968526 |
| 60 | MP0005167_abnormal_blood-brain_barrier | 1.00721120 |
| 61 | MP0003705_abnormal_hypodermis_morpholog | 0.99684968 |
| 62 | MP0005023_abnormal_wound_healing | 0.98431781 |
| 63 | MP0001845_abnormal_inflammatory_respons | 0.94922333 |
| 64 | MP0003879_abnormal_hair_cell | 0.94775093 |
| 65 | MP0005319_abnormal_enzyme/_coenzyme | 0.94407543 |
| 66 | MP0005000_abnormal_immune_tolerance | 0.94134548 |
| 67 | MP0002295_abnormal_pulmonary_circulatio | 0.92329403 |
| 68 | MP0004087_abnormal_muscle_fiber | 0.92282655 |
| 69 | MP0005595_abnormal_vascular_smooth | 0.91717516 |
| 70 | MP0006036_abnormal_mitochondrial_physio | 0.89652486 |
| 71 | MP0003656_abnormal_erythrocyte_physiolo | 0.88880622 |
| 72 | MP0006054_spinal_hemorrhage | 0.88801403 |
| 73 | MP0005387_immune_system_phenotype | 0.88408075 |
| 74 | MP0001790_abnormal_immune_system | 0.88408075 |
| 75 | MP0005620_abnormal_muscle_contractility | 0.87291962 |
| 76 | MP0002876_abnormal_thyroid_physiology | 0.86612239 |
| 77 | MP0002254_reproductive_system_inflammat | 0.86571767 |
| 78 | MP0005365_abnormal_bile_salt | 0.85571602 |
| 79 | MP0009764_decreased_sensitivity_to | 0.85518558 |
| 80 | MP0005257_abnormal_intraocular_pressure | 0.85214773 |
| 81 | MP0000920_abnormal_myelination | 0.84848529 |
| 82 | MP0001853_heart_inflammation | 0.83029452 |
| 83 | MP0001542_abnormal_bone_strength | 0.80262289 |
| 84 | MP0003566_abnormal_cell_adhesion | 0.80075779 |
| 85 | MP0002127_abnormal_cardiovascular_syste | 0.78238287 |
| 86 | MP0003795_abnormal_bone_structure | 0.77489455 |
| 87 | MP0003279_aneurysm | 0.76865777 |
| 88 | MP0000751_myopathy | 0.76821778 |
| 89 | MP0005647_abnormal_sex_gland | 0.76538280 |
| 90 | MP0000767_abnormal_smooth_muscle | 0.74952541 |
| 91 | MP0003186_abnormal_redox_activity | 0.73907745 |
| 92 | MP0000013_abnormal_adipose_tissue | 0.73373403 |
| 93 | MP0002972_abnormal_cardiac_muscle | 0.72154763 |
| 94 | MP0000733_abnormal_muscle_development | 0.71758324 |
| 95 | MP0004947_skin_inflammation | 0.71157118 |
| 96 | MP0000681_abnormal_thyroid_gland | 0.70195312 |
| 97 | MP0003448_altered_tumor_morphology | 0.69490702 |
| 98 | MP0002896_abnormal_bone_mineralization | 0.69281060 |
| 99 | MP0002160_abnormal_reproductive_system | 0.69012222 |
| 100 | MP0005397_hematopoietic_system_phenotyp | 0.66962078 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.35568109 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.35568109 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 5.35568109 |
| 4 | Nuclear cataract (HP:0100018) | 4.06022038 |
| 5 | Hyporeflexia of lower limbs (HP:0002600) | 3.70579262 |
| 6 | Spinal rigidity (HP:0003306) | 3.63298453 |
| 7 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.51795750 |
| 8 | Vacuolated lymphocytes (HP:0001922) | 3.48914788 |
| 9 | Exercise-induced myalgia (HP:0003738) | 3.38304552 |
| 10 | EMG: myopathic abnormalities (HP:0003458) | 3.26660159 |
| 11 | Dysostosis multiplex (HP:0000943) | 3.17568674 |
| 12 | Clumsiness (HP:0002312) | 3.17356249 |
| 13 | Axonal loss (HP:0003447) | 3.16612917 |
| 14 | Resting tremor (HP:0002322) | 3.09400373 |
| 15 | Scapular winging (HP:0003691) | 3.06567380 |
| 16 | Reduced antithrombin III activity (HP:0001976) | 2.99478386 |
| 17 | Diaphragmatic weakness (HP:0009113) | 2.97052235 |
| 18 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.86224546 |
| 19 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.85729027 |
| 20 | Increased variability in muscle fiber diameter (HP:0003557) | 2.78218335 |
| 21 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.77091596 |
| 22 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.76926949 |
| 23 | Muscle fiber inclusion bodies (HP:0100299) | 2.76406455 |
| 24 | Systemic lupus erythematosus (HP:0002725) | 2.74262844 |
| 25 | Abnormality of the calf musculature (HP:0001430) | 2.68368813 |
| 26 | Hematochezia (HP:0002573) | 2.67608416 |
| 27 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.61946861 |
| 28 | Premature rupture of membranes (HP:0001788) | 2.61004000 |
| 29 | Mitral stenosis (HP:0001718) | 2.58300758 |
| 30 | Bulbar palsy (HP:0001283) | 2.47905490 |
| 31 | Ventricular fibrillation (HP:0001663) | 2.47664337 |
| 32 | Neck muscle weakness (HP:0000467) | 2.46250637 |
| 33 | Myoglobinuria (HP:0002913) | 2.41797259 |
| 34 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.41737018 |
| 35 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.41737018 |
| 36 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.41737018 |
| 37 | Sensory axonal neuropathy (HP:0003390) | 2.39157606 |
| 38 | Abnormality of the frontal sinuses (HP:0002687) | 2.39111136 |
| 39 | Aortic aneurysm (HP:0004942) | 2.38093359 |
| 40 | Increased cerebral lipofuscin (HP:0011813) | 2.34711124 |
| 41 | Loss of speech (HP:0002371) | 2.33433943 |
| 42 | Thoracic kyphosis (HP:0002942) | 2.30720741 |
| 43 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.29343024 |
| 44 | Mucopolysacchariduria (HP:0008155) | 2.29343024 |
| 45 | Xanthomatosis (HP:0000991) | 2.27435281 |
| 46 | Glomerulonephritis (HP:0000099) | 2.26901306 |
| 47 | Rimmed vacuoles (HP:0003805) | 2.21872043 |
| 48 | Increased serum ferritin (HP:0003281) | 2.21844393 |
| 49 | Type 1 muscle fiber predominance (HP:0003803) | 2.18789715 |
| 50 | Abnormality of macrophages (HP:0004311) | 2.17471900 |
| 51 | Myocardial infarction (HP:0001658) | 2.16351125 |
| 52 | Disinhibition (HP:0000734) | 2.13546833 |
| 53 | Osteolytic defects of the hand bones (HP:0009699) | 2.13392219 |
| 54 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.13392219 |
| 55 | Muscle fiber splitting (HP:0003555) | 2.10327187 |
| 56 | Frequent falls (HP:0002359) | 2.09556395 |
| 57 | Muscular dystrophy (HP:0003560) | 2.09394229 |
| 58 | Calf muscle hypertrophy (HP:0008981) | 2.07952267 |
| 59 | Rhabdomyolysis (HP:0003201) | 2.06903969 |
| 60 | Symptomatic seizures (HP:0011145) | 2.05616975 |
| 61 | Retinal atrophy (HP:0001105) | 2.04698059 |
| 62 | Spondylolisthesis (HP:0003302) | 2.04536300 |
| 63 | Generalized amyotrophy (HP:0003700) | 2.03633522 |
| 64 | Elbow flexion contracture (HP:0002987) | 2.02865388 |
| 65 | Deep venous thrombosis (HP:0002625) | 2.02837436 |
| 66 | Basal ganglia calcification (HP:0002135) | 1.98330126 |
| 67 | Eosinophilia (HP:0001880) | 1.97925289 |
| 68 | Multiple lipomas (HP:0001012) | 1.97392101 |
| 69 | Abnormality of the intrinsic pathway (HP:0010989) | 1.96471300 |
| 70 | Exercise-induced muscle cramps (HP:0003710) | 1.96006969 |
| 71 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.95609115 |
| 72 | Abnormality of the columella (HP:0009929) | 1.94150554 |
| 73 | Limb-girdle muscle atrophy (HP:0003797) | 1.93233570 |
| 74 | Buphthalmos (HP:0000557) | 1.93120988 |
| 75 | Nemaline bodies (HP:0003798) | 1.92068158 |
| 76 | Hyperkalemia (HP:0002153) | 1.91494470 |
| 77 | Protrusio acetabuli (HP:0003179) | 1.90501809 |
| 78 | Asymmetric septal hypertrophy (HP:0001670) | 1.90081658 |
| 79 | Zonular cataract (HP:0010920) | 1.89598672 |
| 80 | Difficulty climbing stairs (HP:0003551) | 1.87881130 |
| 81 | Myopathic facies (HP:0002058) | 1.86274053 |
| 82 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.84366692 |
| 83 | Increased circulating renin level (HP:0000848) | 1.84311614 |
| 84 | Abnormality of the Achilles tendon (HP:0005109) | 1.84132829 |
| 85 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.83397903 |
| 86 | Achilles tendon contracture (HP:0001771) | 1.82994598 |
| 87 | Abnormality of the basal ganglia (HP:0002134) | 1.79656857 |
| 88 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.79463823 |
| 89 | Hypoglycemic seizures (HP:0002173) | 1.79178350 |
| 90 | Inappropriate behavior (HP:0000719) | 1.75388520 |
| 91 | Thoracolumbar scoliosis (HP:0002944) | 1.74469469 |
| 92 | Purpura (HP:0000979) | 1.74371009 |
| 93 | Vertebral compression fractures (HP:0002953) | 1.74311643 |
| 94 | Complement deficiency (HP:0004431) | 1.74078360 |
| 95 | Apathy (HP:0000741) | 1.74075849 |
| 96 | Protuberant abdomen (HP:0001538) | 1.71918268 |
| 97 | Facial diplegia (HP:0001349) | 1.71020764 |
| 98 | Abnormality of iron homeostasis (HP:0011031) | 1.68625554 |
| 99 | Prolonged neonatal jaundice (HP:0006579) | 1.67865264 |
| 100 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.67491323 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PINK1 | 6.70007849 |
| 2 | NME2 | 4.00039079 |
| 3 | MARK3 | 3.47097005 |
| 4 | OBSCN | 3.20166429 |
| 5 | MYLK | 3.09374204 |
| 6 | IRAK3 | 2.84677031 |
| 7 | MAP3K13 | 2.32668923 |
| 8 | MOS | 2.32516353 |
| 9 | MAP3K3 | 2.11445232 |
| 10 | ARAF | 2.04026375 |
| 11 | LATS1 | 1.98549209 |
| 12 | MAP3K1 | 1.70808595 |
| 13 | LATS2 | 1.68920112 |
| 14 | EIF2AK3 | 1.60233233 |
| 15 | TGFBR2 | 1.58535969 |
| 16 | TBK1 | 1.54487284 |
| 17 | DDR2 | 1.54401524 |
| 18 | TTN | 1.53999057 |
| 19 | MAP3K14 | 1.51728956 |
| 20 | TAOK2 | 1.45136875 |
| 21 | TRPM7 | 1.29538546 |
| 22 | TESK1 | 1.24951529 |
| 23 | NEK2 | 1.23238789 |
| 24 | MAP3K9 | 1.21057274 |
| 25 | PRKG2 | 1.21002720 |
| 26 | MST1R | 1.15960486 |
| 27 | GRK7 | 1.10661451 |
| 28 | PRPF4B | 1.10629243 |
| 29 | PHKG1 | 1.08609033 |
| 30 | PHKG2 | 1.08609033 |
| 31 | TAOK1 | 1.07768279 |
| 32 | ABL2 | 1.07335666 |
| 33 | IRAK4 | 1.06230660 |
| 34 | STK38 | 1.01067577 |
| 35 | ICK | 1.00165397 |
| 36 | IKBKB | 0.94706045 |
| 37 | FRK | 0.94595731 |
| 38 | CLK1 | 0.92476168 |
| 39 | ZAP70 | 0.92370595 |
| 40 | CDC42BPA | 0.91336910 |
| 41 | PAK2 | 0.86327137 |
| 42 | TIE1 | 0.86135457 |
| 43 | BLK | 0.85721226 |
| 44 | RIPK1 | 0.85265476 |
| 45 | MAP2K3 | 0.85113424 |
| 46 | MAP3K5 | 0.84641488 |
| 47 | ERN1 | 0.84176196 |
| 48 | STK38L | 0.82891619 |
| 49 | PDGFRA | 0.82664335 |
| 50 | MAP2K7 | 0.80985618 |
| 51 | IRAK2 | 0.80325792 |
| 52 | MAP2K6 | 0.74663537 |
| 53 | PTK2B | 0.71885148 |
| 54 | PIM2 | 0.71620281 |
| 55 | PDPK1 | 0.69738739 |
| 56 | BMPR2 | 0.69454033 |
| 57 | CDK3 | 0.68404524 |
| 58 | ROCK1 | 0.67997317 |
| 59 | KSR2 | 0.67653100 |
| 60 | DAPK3 | 0.65861438 |
| 61 | PAK1 | 0.65055811 |
| 62 | MAPK12 | 0.64689086 |
| 63 | ILK | 0.64064245 |
| 64 | MAPKAPK3 | 0.62314468 |
| 65 | ADRBK2 | 0.57895483 |
| 66 | STK3 | 0.57112015 |
| 67 | MAPK11 | 0.55647193 |
| 68 | CHUK | 0.54787805 |
| 69 | JAK3 | 0.54453324 |
| 70 | FGR | 0.54144694 |
| 71 | IKBKE | 0.53638312 |
| 72 | PBK | 0.51899148 |
| 73 | PDK2 | 0.51545775 |
| 74 | MELK | 0.49918676 |
| 75 | PRKCQ | 0.48776695 |
| 76 | ROCK2 | 0.48326986 |
| 77 | STK4 | 0.48196348 |
| 78 | MAP3K11 | 0.47711712 |
| 79 | JAK1 | 0.47679193 |
| 80 | RPS6KB1 | 0.47388805 |
| 81 | PIK3CG | 0.47323361 |
| 82 | FGFR3 | 0.46095494 |
| 83 | BRAF | 0.45677997 |
| 84 | MAPKAPK2 | 0.45330173 |
| 85 | MET | 0.45033616 |
| 86 | CSNK1A1L | 0.44708283 |
| 87 | MAP3K12 | 0.44436431 |
| 88 | MAP3K8 | 0.44007958 |
| 89 | NEK9 | 0.43922002 |
| 90 | PTK2 | 0.43320243 |
| 91 | MTOR | 0.42773733 |
| 92 | SCYL2 | 0.41487382 |
| 93 | KSR1 | 0.41414668 |
| 94 | AKT2 | 0.40959854 |
| 95 | PDK1 | 0.39438279 |
| 96 | MUSK | 0.39415398 |
| 97 | SGK494 | 0.38734894 |
| 98 | SGK223 | 0.38734894 |
| 99 | SIK3 | 0.36980454 |
| 100 | PAK4 | 0.36328483 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.76706081 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.45893678 |
| 3 | Lysosome_Homo sapiens_hsa04142 | 2.39238371 |
| 4 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.19236315 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.12292060 |
| 6 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.98573903 |
| 7 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.98237747 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.97268390 |
| 9 | Pertussis_Homo sapiens_hsa05133 | 1.82694311 |
| 10 | Malaria_Homo sapiens_hsa05144 | 1.70517433 |
| 11 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.70054323 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.66737127 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.65248733 |
| 14 | Phagosome_Homo sapiens_hsa04145 | 1.57105778 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.55402257 |
| 16 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.54051426 |
| 17 | Legionellosis_Homo sapiens_hsa05134 | 1.35336672 |
| 18 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.35262290 |
| 19 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.33343822 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 1.32549035 |
| 21 | Salmonella infection_Homo sapiens_hsa05132 | 1.29921480 |
| 22 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.28901952 |
| 23 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.22092583 |
| 24 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.21923467 |
| 25 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.21502931 |
| 26 | Leishmaniasis_Homo sapiens_hsa05140 | 1.20493084 |
| 27 | Mineral absorption_Homo sapiens_hsa04978 | 1.16369298 |
| 28 | Apoptosis_Homo sapiens_hsa04210 | 1.15968337 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.12198960 |
| 30 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.10123807 |
| 31 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.07399919 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.06542273 |
| 33 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.04833041 |
| 34 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.01851612 |
| 35 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.95525614 |
| 36 | Prion diseases_Homo sapiens_hsa05020 | 0.94505161 |
| 37 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.93949546 |
| 38 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.93762572 |
| 39 | Influenza A_Homo sapiens_hsa05164 | 0.92149343 |
| 40 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.91220817 |
| 41 | Focal adhesion_Homo sapiens_hsa04510 | 0.89578022 |
| 42 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.85941131 |
| 43 | Bladder cancer_Homo sapiens_hsa05219 | 0.84133467 |
| 44 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.83753135 |
| 45 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.83241601 |
| 46 | Asthma_Homo sapiens_hsa05310 | 0.81303147 |
| 47 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.80317348 |
| 48 | Insulin resistance_Homo sapiens_hsa04931 | 0.77318751 |
| 49 | Circadian rhythm_Homo sapiens_hsa04710 | 0.77152104 |
| 50 | Galactose metabolism_Homo sapiens_hsa00052 | 0.76811099 |
| 51 | Shigellosis_Homo sapiens_hsa05131 | 0.75925556 |
| 52 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.75111084 |
| 53 | Hepatitis C_Homo sapiens_hsa05160 | 0.74355948 |
| 54 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.73282953 |
| 55 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.73258566 |
| 56 | Allograft rejection_Homo sapiens_hsa05330 | 0.72788170 |
| 57 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.71526165 |
| 58 | Amoebiasis_Homo sapiens_hsa05146 | 0.70638481 |
| 59 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.69977969 |
| 60 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.69504821 |
| 61 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.69309774 |
| 62 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.68818043 |
| 63 | Renin secretion_Homo sapiens_hsa04924 | 0.68714947 |
| 64 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.68340987 |
| 65 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.67953108 |
| 66 | Hepatitis B_Homo sapiens_hsa05161 | 0.67939828 |
| 67 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.67596402 |
| 68 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.67348850 |
| 69 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.67081176 |
| 70 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.66674492 |
| 71 | Platelet activation_Homo sapiens_hsa04611 | 0.65418296 |
| 72 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.65410073 |
| 73 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.64527055 |
| 74 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.64156047 |
| 75 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.63867407 |
| 76 | Gap junction_Homo sapiens_hsa04540 | 0.62900991 |
| 77 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.62120409 |
| 78 | Measles_Homo sapiens_hsa05162 | 0.61824732 |
| 79 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.60168852 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.60118109 |
| 81 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.59933137 |
| 82 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.59728931 |
| 83 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.56813718 |
| 84 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.55435301 |
| 85 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.54823354 |
| 86 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.52740598 |
| 87 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.52368315 |
| 88 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.49452275 |
| 89 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.47737289 |
| 90 | Viral myocarditis_Homo sapiens_hsa05416 | 0.46955193 |
| 91 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.46273753 |
| 92 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.46138117 |
| 93 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.45600455 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.45226390 |
| 95 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.43667990 |
| 96 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.41986161 |
| 97 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.39397076 |
| 98 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.38450856 |
| 99 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.38087253 |
| 100 | Peroxisome_Homo sapiens_hsa04146 | 0.38083042 |

